000			01971 a2200541 4500
005			20250518045855.0
264		0	_c20190909
008			201909s 0 0 eng d
022			_a2041-1723
024	7		_a10.1038/s41467-019-10993-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aNing, Jian-Fang
245	0	0	_aMyc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma. _h[electronic resource]
260			_bNature communications _c07 2019
300			_a2910 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntigens, Surface _xgenetics
650	0	4	_aAtaxia Telangiectasia Mutated Proteins _xgenetics
650	0	4	_aCell Cycle Proteins _xgenetics
650	0	4	_aCyclin-Dependent Kinases _xgenetics
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aGlioblastoma _xdrug therapy
650	0	4	_aHomologous Recombination
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aN-Myc Proto-Oncogene Protein _xgenetics
650	0	4	_aNeoplastic Stem Cells _xmetabolism
650	0	4	_aPoly (ADP-Ribose) Polymerase-1 _xgenetics
650	0	4	_aPoly(ADP-ribose) Polymerase Inhibitors _xadministration & dosage
650	0	4	_aProtein Binding
650	0	4	_aProto-Oncogene Proteins c-myc _xgenetics
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aStanciu, Monica
700	1		_aHumphrey, Melissa R
700	1		_aGorham, Joshua
700	1		_aWakimoto, Hiroko
700	1		_aNishihara, Reiko
700	1		_aLees, Jacqueline
700	1		_aZou, Lee
700	1		_aMartuza, Robert L
700	1		_aWakimoto, Hiroaki
700	1		_aRabkin, Samuel D
773	0		_tNature communications _gvol. 10 _gno. 1 _gp. 2910
856	4	0	_uhttps://doi.org/10.1038/s41467-019-10993-5 _zAvailable from publisher's website
999			_c29863244 _d29863244